LTS Lohmann Therapie-Systeme AG
LTS wins funding from BARDA’s Patch Forward Prize Competition for two partnerships
more
4.5.5
Stories about Biotechnologie
Gerresheimer: FDA grants Tentative Approval of SQ Innovation’s Lasix® ONYU*
more- 10
Gerresheimer: New pictures available
more Gerresheimer expands capacities for Medical Systems in the USA
moreBiomay Announces its Successful Support of Approval of First CRISPR/Cas9-based Therapy
moreSHL Medical further strengthens vertical capabilities with the acquisition of US manufacturer Superior Tooling Inc.
more
Biomay Announces Expansion of GMP-Facilities to Offer mRNA Manufacturing and Aseptic Filling Services
more- 2
R-Biopharm AG announces personnel changes in the Board of Directors and restructuring
more Artilysin® - A Groundbreaking "Green Pharma" Solution
moreBerlin Cures Welcomes Oliver von Stein as New CEO to Lead Next Phase of Innovation and Growth / Phase II study for BC 007 in the indication Long COVID to start in June
moreAmicogen and Lysando: Novel approach for the treatment of mastitis in dairy cows
moreBlood Donation Day at R-Biopharm: Employees Help Save Lives
more
biomindz Standortentwicklungsgesellschaft Mainz GmbH i.G.
Newly established company to promote Mainz as hub for life science and biotechnology now operational and supporting the city of Mainz
moreFlu tests from R-Biopharm also detect new virus variants
moreStem cell therapy for “Butterfly disease” / RHEACELL receives ‘Partners in Progress Award’ from debra of America for Epidermolysis Bullosa research
moreR-Biopharm starts commercialization of the fully automated RIDA®UNITY system for real-time PCR in molecular diagnostic laboratories
moreR-Biopharm is IVDR certified
more- 2
R-Biopharm acquires Australian lab equipment manufacturer and molecular biology multiplex specialist AusDiagnostics
more
R-Biopharm announces test to detect monkeypox virus
moreThe New Era Biotechnology Co., Ltd.
The New Era Biotechnology deepens cooperation between China and Belarus in the Great Stone China Belarus Industrial Park (CBIP)
moreRegulatory breakthrough for BrainRepair UG start-up - Stem cell treatment for newborns /EMA Orphan Drug Designation is followed by agreement on Paediatric Investigation Plan
more
1
